Corrigendum: TAT-HSP27 peptide improves neurologic deficits via reducing apoptosis after experimental subarachnoid hemorrhage

Front Cell Neurosci. 2024 Jun 5:18:1414704. doi: 10.3389/fncel.2024.1414704. eCollection 2024.

Xiao-Yan Zhou^#^{1

2

3

4}, Jing-Yi Sun^#⁵, Wei-Qi Wang^#⁶, Shu-Xian Li^#⁷, Han-Xia Li⁷, Hui-Juan Yang⁷, Ming-Feng Yang⁷, Hui Yuan⁷, Zong-Yong Zhang^{6

7}, Bao-Liang Sun⁷, Jin-Xiang Han^{2

3

4}

¹ Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Shandong University, Ji'nan, China.
² Department of Neurosurgery, First Affiliated Hospital of Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, China.
³ Biomedical Sciences College and Shandong Medicinal Biotechnology Centre, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, China.
⁴ Key Lab for Biotech-Drugs of National Health Commission, Shandong First Medical University and Shandong Academy of Medical Sciences, Ji'nan, China.
⁵ Department of Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
⁶ Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
⁷ Department of Neurology, Key Laboratory of Cerebral Microcirculation, Second Affiliated Hospital of Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fncel.2022.878673.].

Keywords: HSP27; TAT-HSP2765 − 90 peptide; cell apoptosis; neurologic deficits; subarachnoid hemorrhage.